Boston Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $840K | Sell |
42,365
-2,848
| -6% | -$56.5K | 0.04% | 404 |
|
2019
Q2 | $954K | Sell |
45,213
-397
| -0.9% | -$8.38K | 0.05% | 366 |
|
2019
Q1 | $932K | Sell |
45,610
-2,551
| -5% | -$52.1K | 0.05% | 356 |
|
2018
Q4 | $958K | Buy |
48,161
+3,945
| +9% | +$78.5K | 0.06% | 321 |
|
2018
Q3 | $851K | Buy |
44,216
+2,268
| +5% | +$43.7K | 0.04% | 407 |
|
2018
Q2 | $640K | Sell |
41,948
-705
| -2% | -$10.8K | 0.02% | 454 |
|
2018
Q1 | $800K | Buy |
42,653
+2,733
| +7% | +$51.3K | 0.02% | 409 |
|
2017
Q4 | $768K | Buy |
39,920
+1,025
| +3% | +$19.7K | 0.02% | 422 |
|
2017
Q3 | $695K | Buy |
38,895
+3,635
| +10% | +$65K | 0.02% | 426 |
|
2017
Q2 | $630K | Sell |
35,260
-2,080
| -6% | -$37.2K | 0.01% | 445 |
|
2017
Q1 | $541K | Buy |
37,340
+6,700
| +22% | +$97.1K | 0.01% | 450 |
|
2016
Q4 | $564K | Buy |
30,640
+14,735
| +93% | +$271K | 0.01% | 455 |
|
2016
Q3 | $302K | Buy |
+15,905
| New | +$302K | 0.01% | 607 |
|